QPPV.COM KNOWLEDGE ASSESSMENT

EU Pharmacovigilance Inspection Findings: Cross-Functional and Interface Controls

Test your understanding of the concepts covered by EU Pharmacovigilance Inspection Findings: Cross-Functional and Interface Controls.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A safety database outage is managed by IT as a technical incident. What should determine whether it also requires pharmacovigilance assessment?

Whether the incident lasted more than one business day Whether the incident could affect case entry, assessment, submission or reporting timelines Whether the QPPV personally opened the IT ticket Whether the database vendor caused the outage

Question 2 of 10 Why can an inspector identify a pharmacovigilance weakness even when each involved department has an apparently adequate SOP?

Because departmental SOPs are not permitted in an EU pharmacovigilance system Because the transition of information and responsibility between departments may be inadequately controlled Because inspectors assess only the QPPV's personal activities Because every department must use identical procedures

Question 3 of 10 Why can exception cases be particularly valuable when sampling an interface?

They are the only transactions that can be used for regulatory decisions They reveal whether the control can detect, contain and correct deviations from the normal workflow They eliminate the need to sample successful transactions They demonstrate that the normal process is invalid

Question 4 of 10 An affiliate receives a serious safety communication and informs local Regulatory Affairs, which assumes central PV has already been notified. What control would most directly reduce the risk of recurrence?

Allow either function to notify central PV without requiring confirmation Establish one authoritative escalation route with defined ownership, acknowledgement and follow-up Require the affiliate to copy every corporate department on all communications Remove local Regulatory Affairs from the communication process

Question 5 of 10 Which evidence chain best reflects mature inspection readiness for a critical pharmacovigilance interface?

Organisational chart, SOP approval and annual training record Requirement, assigned responsibility, procedure or agreement, actual transaction, control evidence, exception management, oversight and effectiveness evidence Contract, vendor invoice and management presentation Interview statement, informal email and retrospective explanation

Question 6 of 10 An MAH outsources literature screening to a service provider. Which interpretation is most consistent with the EU pharmacovigilance framework described in the article?

The vendor assumes the MAH's ultimate responsibility once the contract is signed The QPPV becomes responsible for performing all outsourced operational tasks personally The MAH may delegate activities but retains ultimate responsibility for its pharmacovigilance system The competent authority becomes responsible for monitoring the vendor's daily performance

Question 7 of 10 What is the most appropriate role of a responsibility assignment matrix in inspection readiness?

It replaces the need for procedures and operational records It proves that assigned activities are being performed effectively It makes responsibilities visible and helps direct the inspector to evidence of actual operation It transfers the MAH's accountability to the person listed as responsible

Question 8 of 10 During a major database migration, which approach best addresses interface risk?

Treat the migration solely as an IT project because the PV process remains unchanged in principle Assess which recipients, decision points, authoritative systems and information flows may change, and control the transition Suspend all PV oversight until the new system is fully operational Rely on the previous system's procedures without reassessing them

Question 9 of 10 Which situation most strongly suggests a systemic interface deficiency rather than an isolated operational error?

One late transfer caused by a documented, corrected individual mistake within an otherwise monitored process Repeated late transfers across multiple functions with no effective monitoring or escalation One transfer that was delayed but detected and reconciled promptly A single formatting error corrected before any downstream deadline was affected

Question 10 of 10 Which effectiveness check best matches a CAPA for late transfers across an interface?

Confirm that the revised SOP was approved Confirm that affected staff attended training Sample post-CAPA transactions for both completeness and transfer timeliness Confirm that the original investigation was closed

QPPV.com

EU Pharmacovigilance Inspection Findings: Cross-Functional and Interface Controls

Cookie Settings